Trade

Max Healthcare Institute share price

Moderate risk
  • 25%Low risk
  • 25%Moderate risk
  • 25%Balanced risk
  • 25%High risk
  • 25%Extreme risk
  • ₹994.15(-0.49%)
    January 23, 2026 15:29:59 PM IST
    • NSE
    • BSE
  • Vol : 2.34 M (NSE + BSE)
    Last 20 day avg : 2.73 M

Max Healthcare Institute is trading -0.49% lower at Rs 994.15 as compared to its last closing price. Max Healthcare Institute has been trading in the price range of 1,007.00 & 987.70. Max Healthcare Institute has given -4.43% in this year & -3.37% in the last 5 days. Max Healthcare Institute has TTM P/E ratio 80.04 as compared to the sector P/E of 26.23.There are 22 analysts who have initiated coverage on Max Healthcare Institute. There are 5 analysts who have given it a strong buy rating & 11 analysts have given it a buy rating. 4 analysts have given the stock a sell rating.The company posted a net profit of 491.30 Crores in its last quarter.Listed peers of Max Healthcare Institute include Apollo Hospitals Enterprise (0.19%), Aster DM Healthcare (-3.17%), Global Health (-3.26%).The Mutual Fund holding in Max Healthcare Institute was at 14.04% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Max Healthcare Institute was at 50.55% in 31 Dec 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 23, 2026, 02:09 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.94
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.32
    In line with industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.15
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    3.48
    Indicates overvaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
987.70
Highest
1,007.00
52 week range
Lowest
940.35
Highest
1,314.30
Max Healthcare Institute News
Max Healthcare Institute Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Apollo Hospitals Enterprise
Bearish
6,809.900.1997,758.4271.0912.560.2683.18
Aster DM Healthcare
Bearish
557.75-3.1728,832.2286.958.680.8453.36
Global Health
Bearish
1,031.00-3.2627,567.4361.739.450.0418.41
Narayana Hrudayalaya
Bearish
1,741.15-1.9035,701.9647.6610.510.2459.03
Fortis Healthcare
Bearish
846.500.6263,808.6180.047.640.1125.92
Mutual Fund Ownership
View all
Motilal Oswal Nifty MidSmall India Consumption Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 1.40
  • % of AUM 9.26
Kotak Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 34.32
  • % of AUM 7.90
WhiteOak Capital Pharma and Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 24.95
  • % of AUM 7.52
PGIM India Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 7.84
  • % of AUM 7.19
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 10.45
  • % of AUM 6.68
Max Healthcare Institute Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-14Quarterly Results
2025-08-13Quarterly Results
2025-05-20Audited Results & Final Dividend
2025-01-30Quarterly Results
2024-11-05Quarterly Results
About the company Max Healthcare Institute
  • IndustryHealthcare Facilities
  • ISININE027H01010
  • BSE Code543220
  • NSE CodeMAXHEALTH
Max Healthcare Institute Limited is an India-based integrated healthcare provider. The Company operates through a single segment, namely Medical and Healthcare Services. It provides a wide array of services, including advanced cardiac care, lung transplants, prostate laser surgery, orthopedics, oncology, neurosciences, transplants, minimal access metabolic and bariatric surgery, and other services, including obstetrics and gynecology, pediatrics and nephrology. The Company also provides outpatient services, including consultations for a range of ailments, preventive health screenings, and laboratory services, as well as radiology, imaging, and emergency services. The Company has two strategic business units (SBUs): Max Lab and Max@Home. The Company owns and operates approximately 22 healthcare facilities across the Delhi NCR, Haryana, Punjab, Uttarakhand, Maharashtra, and Uttar Pradesh. It also offers diagnostic services to patients outside its network.
  • Management Info
  • Abhay SoiExecutive Chairman of the Board, Managing Director
  • Yogesh SareenChief Financial Officer, Senior Director
  • Umesh GuptaChief Human Resources Officer, Senior Director - Human Resources
  • Dhiraj AroraaSenior Vice President - Compliance Officer, Company Secretary
  • D.N. KumarSenior Vice President - Infrastructure
  • Sachin KumarSenior Vice President - Internal Audit
  • Prashant SinghDirector - Information Technology and Chief Information Officer
  • Anas WajidSenior Director and Chief Sales and Marketing Officer
  • Gagan PaltaGeneral Counsel, Director
  • Keshav GuptaSenior Director - Growth, Mergers and Acquisitions and Business Planning
Max Healthcare Institute Share Price FAQs

Max Healthcare Institute is trading at 994.15 as on Fri Jan 23 2026 09:59:59. This is -0.49% lower as compared to its previous closing price of 999.00.

The market capitalization of Max Healthcare Institute is 96750.31 Cr as on Fri Jan 23 2026 09:59:59.

The average broker rating on Max Healthcare Institute is Buy. The breakup of analyst rating is given below -

  • 5 analysts have given a strong buy rating
  • 11 analysts have given a buy rating
  • 2 analysts have given a hold rating
  • 4 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Max Healthcare Institute is 1314.30 whereas the 52 wk low is 940.35

Max Healthcare Institute can be analyzed on the following key metrics -

  • TTM P/E: 80.04
  • Sector P/E: 26.23
  • Dividend Yield: 0.15%
  • D/E ratio: 0.33

Max Healthcare Institute reported a net profit of 1075.88 Cr in 2025.

The Mutual Fund Shareholding was 14.04% at the end of 31 Dec 2025.

Quick Links
EQUITY QUICK LINKS
Max Healthcare Institute QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Business News/Market/Market Stats/  Max Healthcare Institute share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.